Shareholders have to understand that they could post on their company website they got FDA approval for life saving drug Leronlimab for Covid-19 and if the media refuses to let the world know share price will continue to sit at $3.50. Any other stock would be at $25-$30 just on potential never mind the safety or the science or the trail data. Media and shorts taking advantage of lack of media have been 2 biggest problems. They would take a couple million and run a nice 15-30 advertisement now letting the world know they have very safe efficient drug for the world now and waiting for approval as many more die.